Phoenix Wealth Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.22M Sell
12,783
-256
-2% -$55.1K 1.08% 23
2026
Q1
$2.84M Sell
13,039
-631
-5% -$140K 1.12% 22
2025
Q4
$3.12M Sell
13,670
-81
-0.6% -$18.5K 1.2% 20
2025
Q3
$3.18M Sell
13,751
-275
-2% -$56K 1.22% 20
2025
Q2
$2.6M Buy
14,026
+12,087
+623% +$2.25M 1.09% 27
2025
Q1
$406K Sell
1,939
-16
-0.8% -$3.11K 0.18% 87
2024
Q4
$347K Hold
1,955
0.15% 89
2024
Q3
$386K Sell
1,955
-500
-20% -$93.3K 0.18% 88
2024
Q2
$421K Buy
2,455
+40
+2% +$6.63K 0.21% 81
2024
Q1
$440K Hold
2,415
0.27% 72
2023
Q4
$386K Hold
2,415
0.27% 69
2023
Q3
$360K Hold
2,415
0.21% 67
2023
Q2
$325K Hold
2,415
0.19% 78
2023
Q1
$385K Hold
2,415
0.24% 60
2022
Q4
$390K Sell
2,415
-59
-2% -$9.05K 0.23% 55
2022
Q3
$332K Sell
2,474
-32
-1% -$4.59K 0.33% 68
2022
Q2
$384K Buy
+2,506
New +$383K 0.38% 59
2022
Q1
Sell
-2,868
Closed -$388K 92
2021
Q4
$388K Hold
2,868
0.29% 77
2021
Q3
$309K Buy
2,868
+250
+10% +$28.6K 0.23% 89
2021
Q2
$303K Buy
2,618
+21
+0.8% +$2.37K 0.22% 94
2021
Q1
$282K Buy
2,597
+282
+12% +$30.2K 0.22% 86
2020
Q4
$248K Buy
+2,315
New +$222K 0.19% 92

Other funds holding ABBV

Phoenix Wealth Advisors's ABBV Position: Q2 2026 in Review

Phoenix Wealth Advisors reduced its AbbVie (ABBV) stake by 2% in Q2 2026, selling an estimated $55.1K and leaving 12,783 shares worth $3.22M. The position accounts for 1.08% of the portfolio, ranked #23.

Phoenix Wealth Advisors first reported a position in ABBV in Q4 2020 and has held it in 22 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Phoenix Wealth Advisors held 12,783 shares of AbbVie worth $3.22M as of Q2 2026.
  • Phoenix Wealth Advisors sold 256 AbbVie shares in Q2 2026, an estimated $55.1K.
  • AbbVie made up 1.08% of Phoenix Wealth Advisors's portfolio in Q2 2026, its #23 holding.
  • Phoenix Wealth Advisors first reported a position in AbbVie in Q4 2020 and has held it in 22 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Phoenix Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.